IPO registrations (S-1, F-1) · Registrants
DataMeds AI, Inc.
- SEC CIK
- 2030763 · filings on EDGAR ↗
- Former names
- Wellgistics Health, Inc. (2024–2026); Danam Health, Inc (2024–2024)
- Registration
- Form S-1, first filed 2024-07-22, last 2026-11-10; 4 initial registrations, 12 amendments
- Outcome
- Final prospectus filed 2025-02-21; declared effective 2025-02-14
- Industry (SIC)
- Wholesale-Drugs, Proprietaries & Druggists' Sundries 5122
- Incorporated in
- DE
- Business address
- 3000 BAYPORT DRIVE SUITE 950, Tampa, FL 33607
- EIN
- 93-3264234
- Ticker
- MEDS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- DataMeds AI, Inc. on the corporate pages
Offering terms
- Proposed price range
- $4.50–$5.50 per share (S-1/A filed 2025-01-14)
- Final price
- $4.50 per share, within the range (424B4 filed 2025-02-21, an initial public offering)
- Shares sold
- 888,889
- Gross proceeds
- $4,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol WGRX
- Lead underwriters
- Craft Capital (444,445 shares)
- Syndicate
- D. Boral Capital (444,444); Health, Inc; of Contents; and Industry Data; Used Terms
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Wellgistics Health, Inc. EXACT (CIK (EXACT))
Filings 22
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2024-07-22 | S-1 | S-1 (registration) | Danam Health, Inc | 0001493152-24-028706 ↗ |
| 2024-08-02 | S-1/A | S-1/A (amendment) | Danam Health, Inc | 0001493152-24-029990 ↗ |
| 2024-09-27 | S-1/A | S-1/A (amendment) | Danam Health, Inc | 0001493152-24-038464 ↗ |
| 2024-10-21 | S-1/A | S-1/A (amendment) | Wellgistics Health, Inc. | 0001493152-24-041640 ↗ |
| 2024-11-06 | S-1/A | S-1/A (amendment) | Wellgistics Health, Inc. | 0001493152-24-043713 ↗ |
| 2024-12-06 | S-1/A | S-1/A (amendment) | Wellgistics Health, Inc. | 0001493152-24-049098 ↗ |
| 2024-12-18 | S-1/A | S-1/A (amendment) | Wellgistics Health, Inc. | 0001493152-24-050510 ↗ |
| 2025-01-14 | S-1/A | S-1/A (amendment) | Wellgistics Health, Inc. | 0001493152-25-001989 ↗ |
| 2025-02-14 | EFFECT | EFFECT (declared effective) | Wellgistics Health, Inc. | 9999999995-25-000455 ↗ |
| 2025-02-21 | 424B4 | 424B4 (final prospectus) | Wellgistics Health, Inc. | 0001493152-25-007800 ↗ |
| 2025-05-05 | S-1 | S-1 (registration) | Wellgistics Health, Inc. | 0001641172-25-008712 ↗ |
| 2025-05-07 | EFFECT | EFFECT (declared effective) | Wellgistics Health, Inc. | 9999999995-25-001460 ↗ |
| 2025-07-24 | S-1 | S-1 (registration) | Wellgistics Health, Inc. | 0001641172-25-020862 ↗ |
| 2025-08-29 | S-1/A | S-1/A (amendment) | Wellgistics Health, Inc. | 0001641172-25-025830 ↗ |
| 2025-09-12 | S-1/A | S-1/A (amendment) | Wellgistics Health, Inc. | 0001493152-25-013281 ↗ |
| 2025-09-22 | S-1/A | S-1/A (amendment) | Wellgistics Health, Inc. | 0001493152-25-014355 ↗ |
| 2025-09-25 | EFFECT | EFFECT (declared effective) | Wellgistics Health, Inc. | 9999999995-25-003089 ↗ |
| 2025-09-29 | 424B4 | 424B4 (final prospectus) | Wellgistics Health, Inc. | 0001493152-25-015899 ↗ |
| 2026-05-07 | EFFECT | EFFECT (declared effective) | Wellgistics Health, Inc. | 9999999995-26-001537 ↗ |
| 2026-08-07 | S-1 | S-1 (registration) | DataMeds AI, Inc. | 0001493152-26-036665 ↗ |
| 2026-10-09 | S-1/A | S-1/A (amendment) | DataMeds AI, Inc. | 0001493152-26-046608 ↗ |
| 2026-11-10 | S-1/A | S-1/A (amendment) | DataMeds AI, Inc. | 0001493152-26-050986 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-14 | S-1/A | registration statement | $4.50–$5.50 | 900,000 | - | Nasdaq WGRX | 5 | primary document; range, shares headline, cover names 5 | document ↗ | |
| 2025-02-21 | 424B4 | final prospectus | $4.50 | 888,889 | $4,000,000 | Nasdaq WGRX | 6 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 6 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| AJJARAPU SURENDRA K | Director | 5 | 2025–2026 | ||
| ANDERSON DONALD WILLIAM | Director | 2 | 2025 | ||
| Pirani Shafaat | Officer | Chief Clinical Officer | 2 | 2025 | |
| SHANAHAN REBECCA M | Director | 2 | 2025 | ||
| Syed Sajid | Director | 2 | 2025 | ||
| Norton Brian | Officer | Chief Executive Officer | 2 | 2025 | |
| Panchal Nikul | Officer | Chief Pharmacy Officer | 2 | 2025 | |
| Patel Prashant | Director,Officer | Chief Executive Officer; Chief Strategy Officer | 5 | 2025–2026 | |
| DiSiena Mark | Officer | Chief Financial Officer | 1 | 2025 | |
| Kalla Srinivas | Officer | Chief Information Officer | 1 | 2025 | |
| PETERSON MICHAEL L | Director | 2 | 2025 | ||
| Lee Steven Dale | Director | 1 | 2025 | ||
| Fell Donald G. | Director | 1 | 2025 | ||
| Doss Howard A. | Director | 1 | 2025 | ||
| Velez Marlene | Director | 1 | 2026 | ||
| Sherb Eric Michael | Director | 1 | 2026 | ||
| Herman Gary L | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Wellgistics Health, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Wholesale-Drugs, Proprietaries & Druggists' Sundries, FL first:
- PRIORITY HEALTHCARE CORP FL
- Stemtech Corp FL
- JOEY NEW YORK, INC. FL
- FV Pharma International Corp. A6
- Artemis Strategic Investment Corp AZ
- WOMEN FIRST HEALTHCARE INC CA
- China Yongxin Pharmaceuticals Inc. CA
- DAVI LUXURY BRAND GROUP, INC. CA
- Merion, Inc. CA
- FAMILYMEDS GROUP, INC. CT
Interests: Wholesale-Drugs, Proprietaries & Druggists' Sundries